This inventor holds 3 USPTO granted patents and 2 EPO patents. Top assignees: Beijing Pearl Biotechnology Limited Liability Company, Cb Therapeutics, Inc., Crown Bioscience Inc. (Taiwan). Active years: 2016-2018.
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile
Company Filing History:

Years Active: 2016-2018
Title: Innovator Spotlight: Boyu Zhong
Introduction
Boyu Zhong, a prominent inventor hailing from Taicang, China, has made significant contributions to the field of cancer research through his innovative work in the development of therapeutic agents. With a total of three patents to his name, Zhong has demonstrated a compelling commitment to advancing medical science.
Latest Patents
Among Boyu Zhong's most notable patents are two groundbreaking inventions aimed at combatting cancer. The first patent, titled "ALK kinase inhibitor and preparation method and uses thereof," presents a novel ALK kinase inhibitor compound represented by Formula I. This invention includes a pharmaceutical composition that contains the compound and outlines its preparation method for developing drugs that serve as ALK inhibitors targeted at cancer treatment.
The second patent, "Highly selective c-Met inhibitors as anticancer agents," introduces innovative nitrogen-containing, heterocyclic compounds designed to inhibit c-Met, a crucial kinase involved in cancer cell proliferation. This patent details the processes for preparing these compounds and their formulations, highlighting their potential use in treating cell proliferative disorders mediated by c-Met.
Career Highlights
Boyu Zhong has worked at notable companies in the biotechnology sector, including Crown Bioscience Inc. in Taiwan and Beijing Pearl Biotechnology Limited Liability Company. His experiences in these institutions have significantly shaped his research and development capabilities, leading to his impactful inventions.
Collaborations
Throughout his career, Boyu Zhong has collaborated with esteemed colleagues such as Chuan Shih and Deyi Zhang. These partnerships have fostered a productive exchange of ideas and innovation, enhancing the quality of the research and development processes in which they are involved.
Conclusion
Boyu Zhong stands as a testament to the power of innovation in the medical field. With his focused contributions to cancer therapy and his dedication to research, he continues to pave the way for future advancements. His work not only reflects his inventive spirit but also underscores the importance of collaboration in achieving significant breakthroughs in healthcare.
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile